European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Animated Language Learning Ltd

Descripción del proyecto

Una visión más detallada del potencial de los niños autistas

El trastorno del espectro autista (TEA) es un trastorno del desarrollo que afecta a personas de todas las razas, etnias y grupos socioeconómicos. Se calcula que uno de cada sesenta y ocho niños son diagnosticados de TEA, lo cual presenta importantes desafíos sociales, comunicativos y conductuales que afectan a numerosas familias y conducen a una dependencia institucional. Dada la gran variedad de síntomas y alteraciones, suelen aplicarse muchos tratamientos diferentes en función de cada caso individual, lo cual incrementa enormemente el coste. El proyecto ALL, financiado con fondos europeos, cambiará de forma revolucionaria el tratamiento del TEA con una tecnología basada en el método de ALL que posibilitará utilizar una estrategia de intervención basada en hechos en el aprendizaje. Permitirá aprovechar de forma eficaz el potencial de los pacientes con TEA, lo que cambiará sus vidas, y reducirá el coste de los tratamientos.

Objetivo

Animated Language Learning is an Irish high growth company, driving forward a ground breaking innovative approach to the development and education of children with autism. The core team is led by Enda Dodd CEO, a Fortune 200 (Medical devices) New Product Development VP; and Valerie Dodd, head of product development, as well as a teacher/psychologist.
Our two product development professionals, Conor and Eoin Dodd, have emerged from Autism, thanks to the ALL approach.

Our team benefits from inputs from global key opinion leaders across relevant clinical, technical, educational and commercial areas including the University of California and National University Ireland Galway (NUIG), Disney, Adobe, Microsoft and Google are also supporting our efforts. We are a global developer of language development tools for Autistic children (ASD) with our first commercial offering currently undergoing pilot studies in the US, UK, Canada, Ireland and Australia.

Children diagnosed with autism fail to develop communication skills and face long term societal dependency and institutionalisation. The US centres for disease control (CDC) reports US Incident rate is approximately 1:68 births and further that European and Asian rates are similar . Annual costs associated with treating this condition in the US and UK alone across clinical, educational, custodial and lost earnings have been estimated to be $283 billion for a total ASD (autism) population of 4.5 million. Despite substantial differences in healthcare policies in the two countries, life time costs associated with the condition were similar. Multiple peer reviewed studies collated by the CDC indicate that ASD prevalence in Europe and Asia is commensurate with the US / UK study.
We have developed a fundamentally different, life-changing and effective technology which is significantly lower cost, capable of unlocking the potential of those diagnosed with ASD so they can make a contribution to society instead of being a burden.

Convocatoria de propuestas

H2020-EIC-SMEInst-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEInst-2018-2020-1

Régimen de financiación

SME-1 - SME instrument phase 1

Coordinador

ANIMATED LANGUAGE LEARNING LIMITED
Aportación neta de la UEn
€ 50 000,00
Dirección
BRAMBLY HEDGE CAHERGOWAN GALWAY
H91D7TW CLAREGALWAY
Irlanda

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Ireland Northern and Western West
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00